Peptide YY3-36 Decreases Reinstatement of High-Fat Food Seeking during Dieting in a Rat Relapse Model
Open Access
- 24 October 2007
- journal article
- research article
- Published by Society for Neuroscience in Journal of Neuroscience
- Vol. 27 (43) , 11522-11532
- https://doi.org/10.1523/jneurosci.5405-06.2007
Abstract
A major problem in treating obesity is high rates of relapse to maladaptive food-taking habits during dieting. This relapse is often provoked by acute re-exposure to palatable food, food-associated cues, or stress. We used a reinstatement model, commonly used to study relapse to abused drugs, to explore the effect of peptide YY3-36 (PYY3-36) on reinstatement of high-fat (35%, 45 mg pellets) food seeking induced by acute exposure to the pellets (pellet priming), a cue previously associated with pellet delivery (pellet cue), or yohimbine (2 mg/kg, a pharmacological stressor). Rats were placed on a restricted diet (16 g of chow per day) and lever-pressed for the pellets for 9–12 sessions (6 h/d, every 48 h); pellet delivery was paired with a tone–light cue. They were then given 10–20 extinction sessions wherein lever presses were not reinforced with the pellets and subsequently tested for reinstatement of food seeking. Systemic PYY3-36 injections (100–200 μg/kg) decreased pellet priming- and pellet cue-induced reinstatement of food seeking but not yohimbine-induced reinstatement. Arcuate nucleus (Arc) injections of PYY3-36 (0.4 μg per side) decreased pellet priming-induced reinstatement. The attenuation of pellet priming-induced reinstatement by systemic PYY3-36 was reversed by systemic (2 mg/kg) but not Arc (0.5 μg per side) injections of the Y2 receptor antagonist BIIE0246. Arc PYY3-36 injections did not decrease pellet cue-induced reinstatement. Finally, systemic PYY3-36 injections had minimal effects on ongoing food self-administration or heroin priming- or heroin cue-induced reinstatement of heroin seeking. These data identify an effect of systemic PYY3-36 on relapse to food seeking that is independent of Y2 receptor activation in Arc and suggest that PYY3-36 should be considered for the treatment of relapse to maladaptive food-taking habits during dieting.Keywords
This publication has 91 references indexed in Scilit:
- Evidence for sugar addiction: Behavioral and neurochemical effects of intermittent, excessive sugar intakeNeuroscience & Biobehavioral Reviews, 2008
- Toward a model of drug relapse: an assessment of the validity of the reinstatement procedurePsychopharmacology, 2006
- Role of food type in yohimbine- and pellet-priming-induced reinstatement of food seekingPhysiology & Behavior, 2006
- Role of brain dopamine in food reward and reinforcementPhilosophical Transactions Of The Royal Society B-Biological Sciences, 2006
- Blockade of the neuropeptide Y Y2 receptor with the specific antagonist BIIE0246 attenuates the effect of endogenous and exogenous peptide YY(3–36) on food intakePublished by Elsevier ,2005
- Pharmacological Blockade of α2-Adrenoceptors Induces Reinstatement of Cocaine-Seeking Behavior in Squirrel MonkeysNeuropsychopharmacology, 2004
- Inhibition of Food Intake in Obese Subjects by Peptide YY3–36New England Journal of Medicine, 2003
- The role of palatable food and hunger as trigger factors in an animal model of stress induced binge eatingInternational Journal of Eating Disorders, 2003
- Brain Peptides and Obesity: Pharmacologic TreatmentObesity Research, 1995
- Novel generation of hormone receptor specificity by amino terminal processing of peptide YYBiochemical and Biophysical Research Communications, 1992